Additionally, we observed that THZ2 reduces SOX9 protein levels in GBM cells, suggesting that CDK7 inhibition may enhance TMZ sensitivity by suppressing SOX9 expression, similar to its role in triple-negative breast cancer[33]. The gene discussed is CDK7; the disease is glioblastoma.